A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease. uri icon

authors

  • Timmons, James A
  • Phillips, Stuart M
  • Anighoro, Andrew
  • Brogan, Robert J
  • Stahl, Jack
  • Wahlestedt, Claes
  • Farquhar, David Gordon
  • Taylor-King, Jake
  • Volmar, Claude-Henry
  • William E. Kraus, MD

publication date

  • January 17, 2022

published in